Mouse cross linked C-telopeptide of type I collagen (CTX-Ⅰ) ELISA Kit

国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Mouse cross linked C-telopeptide of type I collagen (CTX-Ⅰ) ELISA Kit

產品詳情

引用文獻

產品評價

靶點詳情

產品詳情

引用文獻

產品評價

相關問答

靶點詳情

Most popular with customers

產品中心

信號通路

技術信息

聯系信息

文獻引用 (39) 說明書下載

中文名稱：

小鼠Ⅰ型膠原C端肽(CTX-Ⅰ)酶聯免疫試劑盒
貨號：

CSB-E12782m
規格：

96T/48T
價格：

￥3600/￥2500
促銷：
其他：

產品詳情
產品評價
引用文獻
相關問答
靶點詳情

產品描述：

小鼠Ⅰ型膠原C端肽(CTX-Ⅰ)酶聯免疫試劑盒（CSB-E12782m）為競爭法ELISA試劑盒，定量檢測血清、血漿、組織勻漿.樣本中的CTX-Ⅰ含量。CTX-Ⅰ，即Ⅰ型膠原C端肽，是膠原蛋白分解代謝的關鍵產物，其濃度變化反映骨基質降解活性，常用于骨代謝異常、骨質疏松模型研究及骨相關疾病的機制探索。研究機制涉及CTX-Ⅰ在骨吸收過程中的生成和作用，以及與骨代謝相關疾病的關系。試劑盒檢測范圍為0.23 ng/ml-15 ng/ml.，CTX - Ⅰ是Ⅰ型膠原蛋白分解代謝的關鍵產物，其濃度變化可反映骨基質降解活性，常用于骨代謝異常、骨質疏松模型研究及骨相關疾病的機制探索。科研場景中可用于評估骨吸收標志物水平，例如在骨質疏松動物模型中動態監測骨質流失程度，或結合藥物干預實驗探究骨代謝調控機制。支持科研人員高效完成骨代謝相關的基礎研究與藥效評價。本品僅用于科研，不用于臨床診斷，產品具體參數及操作步驟詳見產品說明書。
別名：

cross linked C-telopeptide of type 1 collagen (CTX-1),_x000D_cross linked C-telopeptide of type I collagen (CTX-I)
縮寫：

CTX-Ⅰ
種屬：

Mus musculus (Mouse)
樣本類型：

serum, plasma, tissue homogenates.
檢測范圍：

0.23 ng/ml-15 ng/ml.
靈敏度：

0.12 ng/ml.
反應時間：

1-5h
樣本體積：

50-100ul
檢測波長：

450 nm
研究領域：

Others
測定原理：

quantitative
測定方法：

Competitive

精密度：

線性度：

To assess the linearity of the assay, samples were spiked with high concentrations of mouse CTX-Ⅰ in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

	Sample	Serum(n=4)
1:1	Average %	84
	Range %	80-92
1:2	Average %	87
	Range %	81-94
1:4	Average %	88
	Range %	82-95
1:8	Average %	93
	Range %	86-98

回收率：

標準曲線：

These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

ng/ml

OD1

OD2

Average

0.195

0.204

0.200

7.5

0.246

0.260

0.253

3.75

0.339

0.348

0.344

1.87

0.518

0.529

0.524

0.94

0.851

0.841

0.846

0.47

1.272

1.253

1.262

0.23

1.838

1.784

1.811

2.512

2.525

2.518

數據處理：

ELISA操作視頻及標曲繪制軟件下載
貨期：

3-5 working days

RKIP regulates bone marrow macrophage differentiation to mediate osteoclastogenesis and H-type vessel formation Z Zheng, S Tao, J Jin, Y Li, L Dai, Z Huang,Nature Communications,2025
Interleukin-3 as a Potential Bone Anabolic Agent in treating Postmenopausal Osteoporosis V Piprode, S Behera, J Karhade, G Pandey, A Prasad,bioRxiv,2025
CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation via NSUN5-mediated m5C modification Z Deng, W Zhong,Scientific Reports,2025
Aqueous extract of Sedum sarmentosum (SS-Ex) promotes bone formation and linear bone growth in a calcium/vitamin D-deficient mouse model DH Jung, HJ Kim, JA Ryuk, BS Ko, YB Kim,Biomedicine & Pharmacotherapy,2025
“Betaone” barley water extract suppresses ovariectomy-induced osteoporosis in vivo and RANKL-induced osteoclast differentiation in vitro Y Lee, HJ Lee, KJ Kim, HB Shin, YA Shin, H Jin,PloS one,2025
Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL—RANK Interaction T Liu, J Li, M Duan, Y Wang, Z Jiang,Journal of Cellular and Molecular Medicine,2024
Altered post-fracture systemic bone loss in a mouse model of osteocyte dysfunction B Osipov, AJ Emami, HC Cunningham, S Orr,JBMR plus,2024
FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism C Cheng, M Deng, C Cheng, H Wu, Y Wang,Journal of Orthopaedic Translation,2024
Loss of ZC4H2, an Arthrogryposis Multiplex Congenita Associated Gene, Promotes Osteoclastogenesis in Mice L Zhu, L Zhang, J Cha, C Li, B Mao,Genes,2024
PCLAF induces bone marrow adipocyte senescence and contributes to skeletal aging L Xie,Bone research,2024
Oleanolic acid exerts bone anabolic effects via activation of osteoblastic 25-hydroxyvitamin D 1-alpha hydroxylase WX Yu,Biomedicine & pharmacotherapy,2024
Activation of TAZ by XMU-MP-1 inhibits osteoclastogenesis and attenuates ovariectomy-induced cancellous bone loss X Li,Biochemical and biophysical research communications,2023
Icariin, a phytoestrogen, exerts rapid estrogenic actions through crosstalk of estrogen receptors in osteoblasts KY Wong,Phytotherapy research,2023
Cervical vertebrae for early bone loss evaluation in osteoporosis mouse models B Teng,Quantitative imaging in medicine and surgery,2023
Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies M Leutner,Biomedicine & pharmacotherapy,2022
Asiatic acid improves high-fat-diet-induced osteoporosis in mice via regulating SIRT1/FOXO1 signaling and inhibiting oxidative stress X Chen,Histology and histopathology,2022
The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice Q Zhou,Aging (Albany NY),2022
Age-related accumulation of advanced oxidation protein products promotes osteoclastogenesis through disruption of redox homeostasis J Zhuang,cell death & disease,2021
SIS3 suppresses osteoclastogenesis and ameliorates bone loss in ovariectomized mice by modulating Nox4-dependent reactive oxygen species Wenzheng Pan,Biochemical pharmacology,2021
Conditional Knockout of PDK1 in Osteoclasts Suppressed Osteoclastogenesis and Ameliorated Prostate Cancer-Induced Osteolysis Y Zhang,Researchsquare,2021
DUSP6 expression is associated with osteoporosis through the regulation of osteoclast differentiation via ERK2/Smad2 signaling B Zhang,Cell death & disease,2021
Conditional knockout of the PDK‐1 gene in osteoblasts affects osteoblast differentiation and bone formation Y Bai,Journal of Cellular Physiology,2021
Hydrogen sulfide protects against particle┸\induced inflammatory response and osteolysis via SIRT1 pathway in prosthesis loosening Liu L,FASEB,2020
Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity Meng J, et al,Biochemical Pharmacology,2019
The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation Chen W, et al,Cell Death and Disease,2019
The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling Xuewu Sun, et al,Redox Biology,2019
A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I Yi Liu, et al,Bone,2019
Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency Monajemi M, et al,Journal of Leukocyte Biology,2019
Absence of Dipeptidyl Peptidase 3 increases oxidative stress and causes bone loss Menale C, et al,Journal of Bone and Mineral Research,2019
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway Zheng L, et al,faseb journal,2019
A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption Yu-te Yang .et al,Life Sciences,2018
Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway TakaakiNoguchi.et al,Biochemical and Biophysical Research Communications,2018
VEGF-C promotes the development of lymphatics in bone and bone loss Devon Hominick.et al,Elife. 2018,2018
A Novel Diterpenoid Suppresses Osteoclastogenesis and Promotes Osteogenesis by Inhibiting Ifrd1-and IκBα-Mediated p65 Nuclear Translocation Xie, Zi\'ang.et al,Journal of Bone and Mineral Research ,2017
Progranulin plays crucial roles in preserving bone mass by inhibiting TNF-a-induced osteoclastogenesis and promoting osteoblastic differentiation in mice Noguchi T. et al,Biochem Biophys Res Commun,2015
HYPOXIA-REPERFUSION AFFECTS OSTEOGENIC LINEAGE AND PROMOTES SICKLE CELL BONE DISEASE Dalle Carbonare L. et al,Blood,2015
Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice Khorasani MS.et al,Arthritis Res Ther.,2015
Progranulin plays crucial roles in preserving bone mass by inhibiting TNF-a-induced osteoclastogenesis and promoting osteoblastic differentiation in mice Noguchi T. et al,Biochem Biophys Res Commun,2015
Altered bone development in a mouse model of peripheral sensory nerve inactivation. Heffner MA et al,J Musculoskelet Neuronal Interact,2014

收起更多

最新研究進展：

Ⅰ型膠原交聯脫氨酸肽（CTX-Ⅰ）是膠原蛋白分解產物之一，它被認為是骨吸收的生物標志物之一。CTX-Ⅰ的檢測可以用于評估骨吸收水平，是一種廣泛應用的臨床診斷指標。最近的研究表明，CTX-Ⅰ還與一些非骨代謝方面的疾病有關，例如心血管疾病、糖尿病、腎臟疾病等。

Intra-assay Precision (Precision within an assay): CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess.

Inter-assay Precision (Precision between assays): CV%<10%

Three samples of known concentration were tested in twenty assays to assess.